tiprankstipranks
Trending News
More News >

Cannara Biotech’s Revenue Soars in Q3 2024

Story Highlights
Cannara Biotech’s Revenue Soars in Q3 2024

Cannara Biotech (TSE:LOVE) has released an update.

Confident Investing Starts Here:

Cannara Biotech Inc. has reported a significant increase in net revenues to $19.5 million for Q3 2024, marking a 22.6% rise from the previous year, alongside a thirteenth consecutive quarter of positive Adjusted EBITDA at $2.8 million. The company, a leader in premium-grade cannabis, is making strategic investments in sales and marketing to boost distribution, market share, and prepare for further cultivation expansion.

For further insights into TSE:LOVE stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App